Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/04/2003WO2003072198A1 The use of a benzenesulfonamide compound in the treatment of obesity
09/04/2003WO2003072197A1 Acc inhibitors
09/04/2003WO2003072196A1 Lower esophagus tissue modifier
09/04/2003WO2003072159A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003WO2003072154A1 Composition and method for coating medical devices
09/04/2003WO2003072141A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
09/04/2003WO2003072140A1 Compression-molded preparions with quick-disintegration properties
09/04/2003WO2003072139A1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
09/04/2003WO2003072138A1 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
09/04/2003WO2003072137A1 Combinations of (a) an atp- competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072130A1 Oxygen carrier system, artificial oxygen carrier and reducing agent
09/04/2003WO2003072124A1 Induction method for cell differentiation
09/04/2003WO2003072121A1 Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
09/04/2003WO2003072120A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis
09/04/2003WO2003072118A1 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
09/04/2003WO2003072114A1 Vascular therapeutics
09/04/2003WO2003072113A1 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
09/04/2003WO2003072112A1 'long'-'acting' injectable parasiticidal composition
09/04/2003WO2003072111A2 Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression
09/04/2003WO2003072110A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
09/04/2003WO2003072109A1 Use of biogenic estriol sulfamate prodrugs for the treatment of autoimmune diseases
09/04/2003WO2003072108A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072106A2 Use of tyrosine kinase inhibitors for treating substance use disorders
09/04/2003WO2003072105A1 Treatment of effect of chemicals with their ultradilute stereoisomers
09/04/2003WO2003072104A1 Preparation of paroxetine involving novel intermediates
09/04/2003WO2003072103A1 Synthetic derivatives
09/04/2003WO2003072102A1 Peroxisome proliferator activated receptor modulators
09/04/2003WO2003072101A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
09/04/2003WO2003072100A1 Peroxisome proliferator activated receptor modulators
09/04/2003WO2003072099A1 Peroxisome proliferator activated receptor modulators
09/04/2003WO2003072098A1 Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase
09/04/2003WO2003072097A1 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
09/04/2003WO2003072096A1 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
09/04/2003WO2003072095A1 Sofalcone-containing compositions
09/04/2003WO2003072094A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
09/04/2003WO2003072093A1 METHOD OF TREATMENT OF HYPERTENSION USING SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRIs)
09/04/2003WO2003072092A1 Methods of treating androgen deficiency in men using selective antiestrogens
09/04/2003WO2003072091A1 Therapeutic methods for acute myeloid leukemia
09/04/2003WO2003072090A2 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003WO2003072089A1 Controlled release dosage forms
09/04/2003WO2003072087A1 Pharmaceutical dosage form and method for the production thereof
09/04/2003WO2003072085A1 Solid preparations with improved absorbability of hardly water-soluble drug
09/04/2003WO2003072082A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
09/04/2003WO2003072071A1 Topical dapsone for the treatment of acne
09/04/2003WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases
09/04/2003WO2003072066A2 Compositions and methods for the treatment of glaucoma and ocular hypertension
09/04/2003WO2003072063A2 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
09/04/2003WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
09/04/2003WO2003072057A2 Intraspinal continuous infusion of midazolam hydrochloride for the treatment of pain
09/04/2003WO2003072056A2 Intranasal administration of mc4-r agonists
09/04/2003WO2003072055A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003WO2003072050A2 Prevention of and therapy for radiation toxicity of normal tissues using drugs which block il-1 activity
09/04/2003WO2003072048A2 Symptomatic relief of gastrointestinal disorders
09/04/2003WO2003072046A2 Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
09/04/2003WO2003072043A2 A method of recuding anti-neoplastic agent induced side effects
09/04/2003WO2003072040A2 Administration of agents for the treatment of inflammation
09/04/2003WO2003072038A2 COMPOSITIONS AND METHODS FOR INHIBITING NF-κB MEDIATED TUMORIGENICITY AND ADHESION-DEPENDENT SURVIVAL OF CANCER CELLS
09/04/2003WO2003072030A2 Methods for preventing or treating cardiac arrhythmia
09/04/2003WO2003072029A2 Methods of extending corneal graft survival
09/04/2003WO2003072028A2 Method of treating hiv infection by preventing interaction of cd4 and gp120
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003072026A2 Method of reducing and treating uvb-induced immunosuppression
09/04/2003WO2003072025A2 Modified release formulations of at least one form of tramadol
09/04/2003WO2003072023A2 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
09/04/2003WO2003072022A2 Oral trimethobenzamide formulations and methods
09/04/2003WO2003072021A2 Oral pediatric trimethobenzamide formulations and methods
09/04/2003WO2003072019A2 Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
09/04/2003WO2003072016A2 Pharmaceutical compositions in particulate form
09/04/2003WO2003072015A2 Compounds useful in the treatment of anthrax
09/04/2003WO2003072013A2 Novel applications of statins in dermatology and corresponding pharmaceutical formulations
09/04/2003WO2003071922A2 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
09/04/2003WO2003071884A1 Compound containing creatine, an acid component and/or a complexing agent
09/04/2003WO2003071872A1 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms
09/04/2003WO2003071870A1 Use of leukotriene receptor antagonist for treatment of scarring
09/04/2003WO2003064451A3 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
09/04/2003WO2003063840A3 Transmucosal delivery of proton pump inhibitors
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003053462A3 Staphylococcus aureus exopolysaccharide and process
09/04/2003WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents
09/04/2003WO2003051302A3 Methods and compositions for treatment of central nervous system disorders
09/04/2003WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors
09/04/2003WO2003047505A3 Topoisomerase poison agents
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003WO2003045306A3 Phenoxy amine compounds and compositions for delivering active agents
09/04/2003WO2003043660A3 Composition for stabilizing hyaluronic acid
09/04/2003WO2003041675A3 Utilization of sterols and their derivatives in cosmetic and dermatological preparations for uva protection
09/04/2003WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
09/04/2003WO2003037304B1 Controlled release compositions for macrolide antimicrobial agents
09/04/2003WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
09/04/2003WO2003034994A9 Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
09/04/2003WO2003033681A3 Composition comprising a lactobacillus pentosus strain and uses thereof
09/04/2003WO2003032961A3 Methods for preventing and treating bone loss with steroid compounds
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003030884A3 Use of solasonine for the treatment of skin tumors
09/04/2003WO2003029244A8 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives
09/04/2003WO2003028739A3 Composition for preventing or treating hyperlipidemia or hyperglycemia comprising a polymer or its salt
09/04/2003WO2003028730A3 Pharmaceutical combinations of pde-v inhibitors and other agents
09/04/2003WO2003024967A3 Indolizines as kinase protein inhibitors
1 ... 5351 5352 5353 5354 5355 5356 5357 5358 5359 5360 5361 5362 5363 5364 5365 5366 5367 5368 5369 5370 5371 ... 7860